Anne S Renteria

Anne S Renteria, MD

  • ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology



Anne S. Renteria, MD, is an assistant professor in the division of Hematology-Oncology at Mount Sinai Hospital. Dr. Renteria’s primary areas of focus are the Hematologic Malignancies and Stem Cell Transplantation. She has clinical and research interest in Graft Versus Host Disease (GVHD). She is the Principal Investigator of two multicenter trials investing GVHD in patients undergoing allogeneic HSCT: the MAGIC (Mount Sinai Acute GVHD International Consortium) trial evaluating the stratification of GVHD through plasma biomarkers predicting treatment response, and the BMT CTN 1202 trial of biomarkers evaluating the GVHD complications. She also is a co-investigator on several studies focused on transplantation and the Hematologic Malignancies.

Dr. Renteria previously was an assistant professor at Boston University, where her research focused on AL amyloidosis and Multiple Myeloma treatments, with clinical focus on autologous HSCT and novel therapies for AL amyloidosis.

A native New Yorker, Dr. Renteria obtained her French Baccalaureate in Mathematics and Sciences in Poitier - France, then a Bachelor’s degree in Genetics at the Federal University of Rio de Janeiro – Brazil. She earned her Medical Degree from the Federal University of Rio de Janeiro School of Medicine, completed her first residency in Internal Medicine in Rio de Janeiro, and then completed a fellowship in Special Immunology – HIV section at the University of Miami. After returning to New York, she completed a second residency in Internal Medicine at Coney Island Hospital. Dr. Renteria completed a fellowship in Hematology-Oncology at Maimonides Medical Center, and subsequently a Bone Marrow Transplant fellowship at Mount Sinai Hospital.

Dr. Renteria lived in different countries and cultural environments, becoming fluent in Spanish, French and Portuguese.


2013 ASBMT Clinical Research Training Course, Santa Fé, NM

2008 – 2009, Chief Resident, Internal Medicine Program, Coney Island Hospital/HHC, Brooklyn, NY

2000 -2001, Member of the Ethics Committee at the Rio de Janeiro Medicine Council (CREMERJ), Federal University of Rio de Janeiro, Brazil


Renteria AS, Sanchorawala V, Niehaus ED, Sun F, Semigran MJ, Seldin DC. “Serum free light chain trends between orthotopic heart transplantation and auto-SCT in patients with AL amyloidosis. Bone Marrow Transplant 2015 March 9 (PMID 25751645)

Bosch N, Renteria AS, Brauneis D, Quillen K, , Seldin D, Sloan M, Sanchorawala V. “Non-operative management of spontaneous splenic rupture in a patient with AL amyloidosis: a case report”. Accepted, Journal of vascular and Interventional Radiology

Freeman B, Brauneis D, Seldin DC, Quillen K, Sloan JM, Renteria AS, Shelton AC, Teschner T, Finn KT, Sanchorawala V. “Hospital admissions following outpatient administration of high-dose melphalan and autologous SCT for AL amyloidosis”. Bone Marrow Transplant 2014; 49(10): 1345-6

Kim SS, Renteria AS, Steinberg A, Banoff K, Isola L. “Pharmacoeconomic impact of up-front use of plerixafor for autologous stem cell mobilization in multiple myeloma patients”. Cytotherapy 2014; 16(11): 1584-9

Renteria AS, B Holland, Y Huang, J Cooper, B Donahue. “Locally advanced pancreatic cancer in a socio-economically challenged population”. Commun Oncol 2013;10:220-226

Renteria AS, Marshall V, Chockalingam P, Sun Y, Cooper J, Huang Y, Whitby D. “A Unique Case of  Classic  Kaposi’s sarcoma restricted to the toes”. J Dermatol Case Rep 2013 Sep 30 (PMID 24133565)

Oliveira AF, Valente JG, Leite IC, Renteria AS, Gadelha AMJ.  “Global Burden of Disease attributable to Diabetes Mellitus in Brazil”. Cad Saúde Pública (Reports in Public Health) 2009;25(6):1234-1244

Linden R, Renteria AS. “Afferent Control of Neuron Numbers in the Developing Brain”. Developmental Brain Research, 1988; 44(2): 291-295

Clinical Trials

Mount Sinai Acute Graft-versus-Host Disease International Consortium (MAGIC): A Database and Biorepository

Prospective Multi-Center Cohort for the Evaluation of Biomarkers Predicting Risk of Complications and Mortality Following Allogeneic HCT (BMT CTN #1202)




Medical Oncology

American Board of Internal Medicine

Clinical Focus

  • AL Amyloidosis
  • Acute Lymphoid Leukemia
  • Acute Myeloid Leukemia
  • Adult Non-Hodgkin's Lymphoma
  • Bone Marrow Transplantation, Allogeneic
  • Bone Marrow Transplantation, Autologous
  • Hematologic Malignancies
  • Hodgkin's Disease
  • Hodgkin's Lymphoma
  • Multiple Myeloma
  • Myelodysplastic Syndromes
  • Myeloproliferative Disorders


MD, Univ. Federal Do Rio De Janeiro

Residency, Internal Medicine, Faculdate De Medicina Da Univ.

Residency, Internal Medicine, Coney Island Hospital

Fellowship, Immunology, Jackson Memorial Hospital

Fellowship, Hematology/Oncology, Maimonides Medical Center

Fellowship, Bone Marrow Trans., Mount Sinai Hospital

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.